![Pei Lan Chu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pei Lan Chu
Director Financiero/CFO en
SYNERGY SCIENTECH CORP.
.
Perfil
Pei Lan Chu is currently the Chief Financial Officer & Deputy General Manager at SYNergy ScienTech Corp.
Prior to this, he worked as the Investment Relations Officer at Tanvex BioPharma, Inc. from 2015 to 2019.
Before that, he was the Director-Biotech Section at President International Development Corp.
Mr. Chu holds an MBA from National Sun Yat-Sen University.
Cargos activos de Pei Lan Chu
| Empresas | Cargo | Inicio |
|---|---|---|
| SYNERGY SCIENTECH CORP. | Director Financiero/CFO | 01/07/2019 |
Antiguos cargos conocidos de Pei Lan Chu.
| Empresas | Cargo | Fin |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Contacto de Relaciones con Inversores | - |
President International Development Corp.
 President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Corporate Officer/Principal | - |
Formación de Pei Lan Chu.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
25
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
National Sun Yat-Sen University
 National Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SYNergy ScienTech Corp.
 SYNergy ScienTech Corp. Electrical ProductsProducer Manufacturing Manufactures rechargeable lithium-ion and lithium-ion polymer batteries | Producer Manufacturing |
President International Development Corp.
President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Finance |
Tanvex BioPharma, Inc.
 Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer | Health Technology |
- Bolsa de valores
- Insiders
- Pei Lan Chu
